Chia et al. showed that there was a significant difference in ALT and AST values between mild and significant fatty liver, although they used broader definition of fatty liver population, which included non-NAFLD patients as well. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.